TGFB1 and B-cell chronic lymphocytic leukemia: Myeloid malignancies like AML, MDS, and CML generally showed higher TGFB1 expression when compared to normal samples and the opposite was seen in lymphoid leukemias (ALL and CLL) (Fig. 2A).